ASTRAZENECA PLC (AZN)
Clinical trial NCT07534592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-18 → 2026-08-28 3. primary completion date: 2026-09-18 → 2026-08-28 4. enrollment: 40 → 48 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical